Skip to main content
Skip to section navigation
Skip to footer
About Us
Company Overview
Management
Board of Directors
Pipeline
Pipeline Overview
Paxalisib
PD-L1 Protein Degrader
SETDB1 Inhibitor
EVT801
Clinical Trials
Posters & Publications
Technology
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Investors
Investors Overview
News & Events
Company Info
Financial Results
Stock Data
SEC Filings
Governance
ASX Delisting
Contact Us
ASX Announcements
Media Center
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Jun 8, 2023
Launch of LUMOS2 Study
Jun 7, 2023
Constitution
Jun 5, 2023
Appointment of Non-executive Director
May 26, 2023
Kazia CEO participates in White House Cancer Moonshot Forum
May 25, 2023
Cancel - Notification of cessation of securities - KZA
May 8, 2023
Notification regarding unquoted securities - KZA
May 5, 2023
Notification of cessation of securities - KZA
May 2, 2023
Final Director's Interest Notice - Dr J Garner
May 1, 2023
Executive Leadership changes - Dr John Friend appointed CEO
Apr 28, 2023
Quarterly Activities/Appendix 4C Cash Flow Report
rss_feed
RSS
Previous Page
arrow_back
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
…
Page
19
Next Page
arrow_forward
Select a page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19